BNET Industries

Last Fiscal Year Sales:$300.0M
  • Private
  • US
Dow Jones Description

We are a diagnostics business that delivers personalized disease management through a combination of products and services incorporating proprietary discoveries. We are organized into three reporting segments, a clinical laboratory testing service business (Lab Services), a products business (Products), and a segment that includes other activities under corporate management (Corporate). Our Lab Services business, conducted through Berkeley HeartLab, Inc. (BHL), offers a broad portfolio of clinical laboratory tests and disease management services designed to help healthcare providers improve cardiovascular disease treatment regimens for patients. Our Products business develops, manufactures, and oversees the commercialization of molecular diagnostic products. Most of this business is conducted through distribution and royalty agreements with Abbott Molecular, a subsidiary of Abbott Laboratories. Our Corporate segment includes revenues from royalties, licenses, funded collaborations and milestones related to the licensing of certain intellectual property and from our former small molecule and proteomic programs.

Chairman, President and Chief Executive Officer
Tony L. White
Number of Employees 749
Contact Information

1401 Harbor Bay Pkwy

Alameda, California 94502-7070

www.celera.com

1 510 749 1853

NAICS Code In-Vitro Diagnostic Substance Manufacturing: 325413

News & Analysis

celera genomics - All News and Analysis

Decision Makers

Name (plus bio) Position
Christopher Hall Chief Business Officer
James Yee Chief Scientific Officer
Joel R. Jung Chief Financial Officer
Paulette Dillon Chief Business
Peter Young Chief Scientific Officer
Robert Booth Chief Scientific Officer
Stacey R. Sias Vice President & Chief Business Officer
Tom White Cso & Vice President, Research
Ugo Deblasi Chief Financial Officer
Kathy P. Ordonez Senior Vice President, Applera and President, Celera Genomics and Celera Diagnostics
Barbara J. Kerr Vice President, Human Resources
Michael A. Zoccoli Vice President & Gm, Ivd Products Division
Michael J Green Vice President, Chemistry
Paul D. Arata Vice President, Human Resources and Administration
Scott K. Milsten Vice President, General Counsel and Corporate Secretary
Victor K Lee Senior Patent Attorney
Jean-Luc Belingard Director

Board of Directors

Name (plus bio) Position
Tony L. White Chairman, President and Chief Executive Officer
Bennett M. Shapiro Board of Directors
Gail K. Naughton Board of Directors
Richard H. Ayers Board of Directors
Wayne I. Roe Board of Directors
William G Green Board of Directors

Organization Position Status
Applied Biosystems Group Chairman and Chief Executive Officer Current
Applera Corporation Chairman, President & CEO Current
Celera Genomics Chairman, President and Chief Executive Officer Current
Celera Diagnostics, LLC Current
Centenary College Board of Directors Current
Ingersoll-Rand Company Limited Director Current
C.R. Bard, Inc. Board of Directors Current
Productivity Inc. Director Current
PerkinElmer, Inc. Chief Executive Officer Former
C.R. Bard, Inc. Chairman, President and Chief Executive Officer, Applera Corporation Former
PerkinElmer, Inc. President Former
Baxter International Inc. Executive Vice President Former
AT&T Inc. Director Former
AT&T Inc. Board of Directors Former

Organization Position Status
Celera Genomics Chief Business Officer Current

Organization Position Status
Celera Genomics Chief Scientific Officer Current
Xdx, Inc. Chief Medical Officer Current
Roche Bioscience Vice President, Clinical and Preclinical Research Former
Syntex Corporation Former
University of California, Berkeley Bachelor's Degree Former

Joel R. Jung, age 50, has served as our Chief Financial Officer since February 2008. Mr. Jung joined Applied Biosystems Celera group as Vice President of Finance in 2006. From 1995 to 2006, Mr. Jung held various management and finance positions with Chiron Corporation, an international manufacturer of biopharmaceuticals, vaccines, and blood testing products, including Vice President and Treasurer from 2003 to 2006.

Organization Position Status
Celera Genomics Chief Financial Officer Current

Organization Position Status
Celera Genomics Chief Business Current

Organization Position Status
Celera Genomics Chief Scientific Officer Current
Genelabs Technologies, Inc. Genelabs' Vice President, Biology Current
Pfizer Inc. Former
GlaxoSmithKline Plc Former
University of Pennsylvania Ph.D. In Molecular Former
University of Oxford B.A. Former

Organization Position Status
Celera Genomics Chief Scientific Officer Current
Virobay Inc. Board of Directors Current
Hoffmann-La Roche Inc. Former
Roche Bioscience Former
University of London PhD In Biochemistry Former
University of London BSc in Biochemistry Former

Organization Position Status
Celera Genomics Vice President & Chief Business Officer Current

Organization Position Status
Western Genomics Chief Scientific Officer and Vice President of R&D for Western Genomics Current
Celera Genomics Cso & Vice President, Research Current
Cetus Corporation Former
Roche Molecular Systems, Inc. Former
University of California, Berkeley Ph.D. In Biochemistry Former
The Johns Hopkins University B.A. In Chemistry Former

Organization Position Status
Celera Genomics Chief Financial Officer Current

Organization Position Status
Applied Biosystems Group President Current
Celera Genomics Group President Current
Applera Corporation Senior Vice President Current
Celera Genomics Senior Vice President, Applera and President, Celera Genomics and Celera Diagnostics Current
Celera Genomics CEO and Director Current
Roche Molecular Systems, Inc. Chief Executive Officer Former
Applera Corporation Chief Executive Officer Former
Celera Genomics President Former
Applera Corporation President Former
Hoffmann-La Roche Inc. President Former
Roche Molecular Systems, Inc. President Former
Celera Genomics President Former
Celera Diagnostics, LLC President Former
Applied Biosystems Group Senior Vice President, Applera Corporation, President, Celera Genomics and Celera Diagnostics Former
Union Carbide Corporation Former
Roche Former
Applera Corporation Chairman Former
Hartwick College Bachelor's Degree In Chemistry Former

Organization Position Status
Applied Biosystems Group Senior Vice President, Human Resources Current
Celera Genomics Vice President, Human Resources Current
PerSeptive BioSystems, Inc. Vice President, HR Current
Applera Corporation Vice President, Human Resources Current
Celera Diagnostics, LLC Current
Applera Corporation Board of Directors Current
Chiron Vice President, Human Resources Former
Applied Biosystems Group Vice President, Human Resources, Applera Corporation Former
Applied Biosystems Group Human Resources Executive Former
Golden Gate University Master’S of Business Aministration Former
University of Rochester Master’S of Education Former
Wittenberg University Bachelor’S Degree In American Studies Former
Applera Corporation Member Former

Michael A. Zoccoli , age 57, has served as our General Manager, Products Business since February 2008. He joined Applied Biosystems Celera group in January 2002, and held various positions, including Vice President of Development, Vice President of Development, Instruments Systems and Software, and Vice President of Development and Manufacturing, prior to being named to his current position. He previously worked in product development and project management at a number of companies, including Cetus Corporation, Roche Molecular Systems, Applied Imaging Corporation, and Bayer Diagnostics.

Organization Position Status
Celera Genomics Vice President & Gm, Ivd Products Division Current
Celera Genomics General Manager, Products Business Former

Organization Position Status
Celera Genomics Vice President, Chemistry Current
Axys Pharmaceuticals Former
Schering-Plough Corporation Former

Paul D. Arata , age 53, has served as our Vice President of Human Resources and Administration since February 2008. Prior to joining Applied Biosystems Celera group, Mr. Arata held various human resources positions with Applied Biosystems from 2001 to 2008, most recently serving as Vice President of Human Resources and Site Services. Prior to joining Applied Biosystems, Mr. Arata held various human resources and administrative and management roles with Charles Schwab & Co., Inc., SBC Communications Inc. and Pacific Telesis Group.

Organization Position Status
Celera Genomics Vice President, Human Resources and Administration Current
Site Services Inc. Former

Organization Position Status
Celera Genomics Vice President, General Counsel and Corporate Secretary Current
Celera Genomics Board of Directors Current

Organization Position Status
Western Genomics Vice President and Chief Group Counsel Current
Western Genomics Senior Licensing Director Current
Celera Genomics Senior Patent Attorney Current
Western Genomics Patent Attorney Current
Celera Genomics Secretary Current
Roche Molecular Systems, Inc. Chief Patent Counsel Former
University of Washington Ph.D. In Experimental Pathology Former
Brooklyn Law School J.D. Former
Eastern Washington University Bachelor of Science Former

Organization Position Status
Mind and Life Institute Co Executive Vice President, Worldwide Licensing and Current
Pure Tech Incorporated Partner Current
PureTech Ventures Venture Partner Current
Gelesis Inc. Partner Current
Protein Forest, Inc. Venture Partner, Scientific Advisory Board Member and Board of Directors Member of Puretech Ventures Current
Garrison Institute Partner at Puretech Ventures Current
The Harvard-MIT Division of Health Sciences and Technology Advisory Committee Member Current
Elixir Pharmaceuticals, Inc. Board of Directors Current
Elixir, LLC. Board of Directors Current
Mersana Therapeutics, Inc Board of Directors Current
Bg Medicine, Inc. Board of Directors Current
Mind and Life Institute Co Board of Directors Current
PureTech Ventures Director Current
Ikaria, Inc. Board Member Current
Momenta Pharmaceuticals, Inc. Director Current
Celera Genomics Board of Directors Current
Enlight Biosciences Board of Directors Current
Momenta.Com Board of Directors Current
Merck & Co. Inc. Executive Vice President Former
University of Washington Professor Former
Institut Pasteur visiting scientist Former
University of Washington Chairman of the Department of Biochemistry Former
Jefferson Medical College of Thomas Jefferson University M.D. Former
Dickinson College B.S. In Chemistry Former
Jefferson Medical College of Thomas Jefferson University Degree In Medicine Former

Gail K. Naughton, age 52, has served as a director of Celera since July 2008. Dr. Naughton has been Dean of the College of Business Administration at San Diego State University since August 2002 and Chairman and Chief Executive Officer of Histogen, Inc., a regenerative medicine company, since June 2007. She was Vice Chairman of Advanced Tissue Sciences, Inc., a company involved in human-based tissue engineering, from March 2002 to October 2002, President from August 2000 to March 2002, President and Chief Operating Officer from 1995 to 2000, and co-founder and director since inception in 1991. She is also a director of C.R. Bard, Inc. and SYS.

Organization Position Status
Histogen, Inc. Chief Executive Officer Current
C.R. Bard, Inc. Dean, College of Business Administration, San Diego State University Current
San Diego State University Dean Current
Xsilogy, Inc. Board of Directors, Chairman of Nominating and Compensation Committee Current
Histogen, Inc. Chairman Current
SYS Technologies, Inc. Director Current
C.R. Bard, Inc. Director Current
Celera Genomics Board of Directors Current
Carmell Therapeutics Corporation Board of Directors Current
Advanced Tissue Sciences, Inc. President Former
Advanced Tissue Sciences, Inc. Chief Operating Officer Former
Advanced Tissue Sciences, Inc. Co-Founder Former
Advanced Tissue Sciences, Inc. Vice Chairman Former
University of California, Los Angeles Mba Former
San Diego State University Business Administration Former

Jean-Luc Belingard (60) has served as a director of the Company since April 28, 1995. Mr. Belingard is Chairman and Chief Executive Officer of Ipsen SA, a diversified French health care holding company, and has served in that position since 2001. Prior to this position, Mr.

Organization Position Status
Ipsen S.A. Chief Executive Officer Current
Ipsen S.A. Chairman Current
Laboratory Corporation of America Holdings Board of Directors Current
Celera Genomics Director Current
Applera Corporation Director Former

Mr. Ayers is the retired Chairman and Chief Executive Officer of The Stanley Works, a tool and hardware manufacturer. He was an advisor to the Chairman and Chief Executive Officer of Stanley from January 1997 to October 1997 after having served as Chairman and Chief Executive Officer of Stanley from May 1989 to December 1996. Mr. Ayers is a Trustee of MassMutual Institutional Funds and MML Series Investment Fund and a director of Instron Corporation.

Organization Position Status
Applera Corporation Committee Member Current
Celera Diagnostics, LLC Current
The Stanley Works Chairman Current
Instron Corporation Director Current
Applera Corporation Director Current
Celera Genomics Board of Directors Current
Applied Biosystems Group Board of Directors Current
Applied Biosystems Group Committee Member Current
Olink Committee Member Current
The Stanley Works Chief Executive Officer Former

Organization Position Status
Celera Genomics Board of Directors Current

Organization Position Status
Gordon and Betty Moore Foundation Chief Program Officer and General Counsel Current
Celera Genomics Board of Directors Current
Brobeck, Phleger & Harrison Partner Former
Gordon and Betty Moore Foundation General Counsel Former
Yale University Undergraduate Degree Former

Executive News

  • Steven Holtzman Joins Satori Pharmaceuticals' Board of Directors

    Globe Investor - 9/03/09 - View Story

  • Strategic Product Development Expert to Educate Utah Technology Company Executives

    Business Wire - 9/01/09 - View Story

  • UPDATE 1-Leerink Swann raises Boston Scientific to outperform

    Forbes.com - 8/18/09 - View Story

advertisement
advertisement
Click Here